ResearcherHong Kong Baptist UniversityActive in the last 2 years

Wenqing Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2557-8960; OpenAlex author ID A5100628712. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Licochalcone A suppresses pancreatic ductal adenocarcinoma progression by targeting eEF2K-mediated pyroptosis. Co-author DOI 10.3389/fphar.2025.1595686 ↗
MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma. Co-author PMID 35968328 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Junjie Peng · 1 shared paper, 2025 · strength 0.30
- Paper Licochalcone A suppresses pancreatic ductal adenocarcinoma progression by targeting eEF2K-mediated pyroptosis. DOI 10.3389/fphar.2025.1595686 ↗
Zhu Zhang · 1 shared paper, 2025 · strength 0.30
- Paper Licochalcone A suppresses pancreatic ductal adenocarcinoma progression by targeting eEF2K-mediated pyroptosis. DOI 10.3389/fphar.2025.1595686 ↗
Zhu Zhang · 1 shared paper, 2022 · strength 0.22
- Paper MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma. PMID 35968328 ↗
Joshua Ka-Shun Ko · 1 shared paper, 2022 · strength 0.22
- Paper MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma. PMID 35968328 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.